Gremlin 2 Promotes Differentiation of Embryonic Stem Cells to Atrial Fate by Activation of the JNK Signaling Pathway

Authors

  • Vineeta Tanwar,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    Search for more papers by this author
  • Jeffery B. Bylund,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    2. Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Jianyong Hu,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    Search for more papers by this author
  • Jingbo Yan,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    2. Department of Cell & Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Joel M. Walthall,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    Search for more papers by this author
  • Amrita Mukherjee,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    Search for more papers by this author
  • William H. Heaton,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    Search for more papers by this author
  • Wen-Der Wang,

    1. Department of Cell & Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA
    2. Department of Medicine, Division of Genetic Medicine, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Franck Potet,

    1. Department of Medicine, Division of Genetic Medicine, Vanderbilt University, Nashville, Tennessee, USA
    2. Department of Anesthesiology, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Meena Rai,

    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    2. Department of Cell & Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Sabina Kupershmidt,

    1. Department of Anesthesiology, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Ela W. Knapik,

    1. Department of Cell & Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA
    2. Department of Medicine, Division of Genetic Medicine, Vanderbilt University, Nashville, Tennessee, USA
    Search for more papers by this author
  • Antonis K. Hatzopoulos

    Corresponding author
    1. Department of Medicine, Division of Cardiovascular Medicine, Nashville, Tennessee, USA
    2. Department of Cell & Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA
    • Correspondence: Antonis K. Hatzopoulos, Ph.D., Department of Medicine and Department of Cell and Developmental Biology, Division of Cardiovascular Medicine–MRB IV P425C, 2213 Garland Avenue, Nashville, Tennessee 37232-6300, USA. Telephone: +1-615-936-5529; Fax: +1-615-936-1872; e-mail: antonis.hatzopoulos@vanderbilt.edu

    Search for more papers by this author

Abstract

The bone morphogenetic protein antagonist Gremlin 2 (Grem2) is required for atrial differentiation and establishment of cardiac rhythm during embryonic development. A human Grem2 variant has been associated with familial atrial fibrillation, suggesting that abnormal Grem2 activity causes arrhythmias. However, it is not known how Grem2 integrates into signaling pathways to direct atrial cardiomyocyte differentiation. Here, we demonstrate that Grem2 expression is induced concurrently with the emergence of cardiovascular progenitor cells during differentiation of mouse embryonic stem cells (ESCs). Grem2 exposure enhances the cardiogenic potential of ESCs by 20–120-fold, preferentially inducing genes expressed in atrial myocytes such as Myl7, Nppa, and Sarcolipin. We show that Grem2 acts upstream to upregulate proatrial transcription factors CoupTFII and Hey1 and downregulate atrial fate repressors Irx4 and Hey2. The molecular phenotype of Grem2-induced atrial cardiomyocytes was further supported by induction of ion channels encoded by Kcnj3, Kcnj5, and Cacna1d genes and establishment of atrial-like action potentials shown by electrophysiological recordings. We show that promotion of atrial-like cardiomyocytes is specific to the Gremlin subfamily of BMP antagonists. Grem2 proatrial differentiation activity is conveyed by noncanonical BMP signaling through phosphorylation of JNK and can be reversed by specific JNK inhibitors, but not by dorsomorphin, an inhibitor of canonical BMP signaling. Taken together, our data provide novel mechanistic insights into atrial cardiomyocyte differentiation from pluripotent stem cells and will assist the development of future approaches to study and treat arrhythmias. Stem Cells 2014;32:1774–1788

Ancillary